Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
1.
Health Policy ; 129: 104702, 2023 Mar.
Article in English | MEDLINE | ID: mdl-36588068

ABSTRACT

The systematic use of patient-reported measures (PRMs) [i.e., patient-reported outcome measures (PROMs) and patient-reported experience measures (PREMs)] is advocated as an effective way to improve care practices. However, whether PRMs can lead to the performance assessment of healthcare organisations (HCOs) through valid quality indicators (QIs) for national purposes (i.e., public reporting and paying for performance) is open to debate. This study undertakes a scoping review to examine the use of PRMs as QIs for health policy purposes and to identify the challenges faced in the emblematic case of oncology. According to PRISMA guidelines, published papers, websites and reports published by national and international initiatives were analysed using five online databases (Web of Science, Scopus, PubMed, JSTOR and Google Advanced Search), and then studied using the same keywords. We selected 61 articles and 19 websites/reports and identified 29 PREMs and 48 PROMs from 14 countries and two international initiatives that routinely used them as QIs for HCOs' comparisons. Four types of barriers to this specific use were identified relating to the definition of a standard set, scientific soundness, data collection, and the actionability of such measures. Despite current developments, different barriers still must be overcome before PRMs can be used for health policy purposes in oncology. Future research is needed to ensure that valid QIs related to PRMs are applied at a national level.


Subject(s)
Patient Reported Outcome Measures , Quality Indicators, Health Care , Humans , Data Collection , Delivery of Health Care , Medical Oncology
2.
Crit Rev Food Sci Nutr ; 59(10): 1546-1562, 2019.
Article in English | MEDLINE | ID: mdl-29359955

ABSTRACT

During the last decade, there has been a growing interest in understanding the fate of food during digestion in the gastrointestinal tract in order to strengthen the possible effects of food on human health. Ideally, food digestion should be studied in vivo on humans but this is not always ethically and financially possible. Therefore simple static in vitro digestion models mimicking the gastrointestinal tract have been proposed as alternatives to in vivo experiments but these models are quite basic and hardly recreate the complexity of the digestive tract. In contrast, dynamic models that allow pH regulation, flow of the food and injection in real time of digestive enzymes in the different compartments of the gastrointestinal tract are more promising to accurately mimic the digestive process. Most of the systems developed so far have been compared for their performances to in vivo data obtained on animals and/or humans. The objective of this article is to review the validation towards in vivo data of some of the dynamic digestion systems currently available in order to determine what aspects of food digestion they are able to mimic. Eight dynamic digestion systems are presented as well as their validation towards in vivo data. Advantages and limits of each simulator is discussed. This is the result of a cooperative international effort made by some of the scientists involved in Infogest, an international network on food digestion.


Subject(s)
Biomimetics/methods , Digestion/physiology , Food , In Vitro Techniques , Models, Biological , Animals , Fermentation , Gastrointestinal Tract/physiology , Humans , Hydrogen-Ion Concentration , Nutrients
3.
J Food Sci ; 75(7): R151-62, 2010 Sep.
Article in English | MEDLINE | ID: mdl-21535567

ABSTRACT

UNLABELLED: During gastric digestion, food is disintegrated by a complex interaction of chemical and mechanical effects. Although the mechanisms of chemical digestion are usually characterized by using in vitro analysis, the difficulty in reproducing the stomach geometry and motility has prevented a good understanding of the local fluid dynamics of gastric contents. The goal of this study was to use computational fluid dynamics (CFD) to develop a 3-D model of the shape and motility pattern of the stomach wall during digestion, and use it to characterize the fluid dynamics of gastric contents of different viscosities. A geometrical model of an averaged-sized human stomach was created, and its motility was characterized by a series of antral-contraction waves of up to 80% relative occlusion. The flow field within the model (predicted using the software Fluent™) strongly depended on the viscosity of gastric contents. By increasing the viscosity, the formation of the 2 flow patterns commonly regarded as the main mechanisms driving digestion (i.e., the retropulsive jet-like motion and eddy structures) was significantly diminished, while a significant increase of the pressure field was predicted. These results were in good agreement with experimental data previously reported in the literature, and suggest that, contrary to the traditional idea of a rapid and complete homogenization of the meal, gastric contents associated with high viscous meals are poorly mixed. This study illustrates the capability of CFD to provide a unique insight into the fluid dynamics of the gastric contents, and points out its potential to develop a fundamental understanding and modeling of the mechanisms involved in the digestion process. PRACTICAL APPLICATION: This study illustrates the capability of computational fluid dynamic techniques to provide a unique insight into the dynamics of the gastric contents, pointing out its potential to develop a fundamental understanding and modeling of the human digestion process.


Subject(s)
Digestion , Hydrodynamics , Models, Anatomic , Stomach/physiology , Computational Biology/methods , Gastrointestinal Motility , Humans , Stomach/anatomy & histology
6.
Bone Marrow Transplant ; 30(12): 967-70, 2002 Dec.
Article in English | MEDLINE | ID: mdl-12476292

ABSTRACT

The management of invasive aspergillosis in patients with hematological malignancies remains controversial. A major problem is how to manage patients who had invasive aspergillosis during remission induction and consolidation therapy and then undergo SCT. Indeed in these patients the mortality rate related to invasive aspergillosis recurrence remains unacceptably high. We report two cases of patients who underwent remission induction for AML, developed invasive aspergillosis during antifungal prophylaxis with itraconazole, failed amphotericin B deoxycholate and liposomal amphotericin B treatment, were successfully treated with voriconazole and eventually underwent SCT with voriconazole prophylaxis without reactivation of invasive aspergillosis.


Subject(s)
Aspergillosis/drug therapy , Bone Marrow Transplantation/adverse effects , Deoxycholic Acid/analogs & derivatives , Leukemia, Megakaryoblastic, Acute/therapy , Leukemia, Myelomonocytic, Acute/therapy , Lung Diseases, Fungal/drug therapy , Peripheral Blood Stem Cell Transplantation/adverse effects , Pyrimidines/therapeutic use , Triazoles/therapeutic use , Adult , Amphotericin B/administration & dosage , Amphotericin B/therapeutic use , Antineoplastic Combined Chemotherapy Protocols/adverse effects , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Aspergillosis/etiology , Aspergillosis/prevention & control , Combined Modality Therapy , Cytarabine/administration & dosage , Cytarabine/adverse effects , Daunorubicin/administration & dosage , Daunorubicin/adverse effects , Deoxycholic Acid/administration & dosage , Deoxycholic Acid/therapeutic use , Drug Combinations , Drug Resistance, Fungal , Etoposide/administration & dosage , Etoposide/adverse effects , Fatal Outcome , Humans , Immunocompromised Host , Itraconazole/therapeutic use , Leukemia, Megakaryoblastic, Acute/complications , Leukemia, Megakaryoblastic, Acute/drug therapy , Leukemia, Myelomonocytic, Acute/complications , Leukemia, Myelomonocytic, Acute/drug therapy , Liposomes , Male , Middle Aged , Recurrence , Remission Induction , Salvage Therapy , Transplantation Conditioning/adverse effects , Transplantation, Autologous/adverse effects , Transplantation, Homologous/adverse effects , Voriconazole
7.
Arch Sci Med (Torino) ; 139(4): 509-12, 1982.
Article in Italian | MEDLINE | ID: mdl-7168642

ABSTRACT

The importance of physiokinesitherapy in the prevention and cure of postoperative complications is emphasised. Thoracic as well as general and other specialised surgery is shown to benefit from physiokinesitherapy exercises. The postoperative complications most likely to benefit from physiokinesitherapy are listed, the techniques most often used in thoracic cases are described and two routine pre- and postoperative programmes are outlined. In conclusion a more widespread systematic use of physiokinesitherapy after thoracic surgery is recommended.


Subject(s)
Exercise Therapy/methods , Thoracic Surgery , Humans , Postoperative Care/methods , Postoperative Complications/prevention & control , Preoperative Care/methods
SELECTION OF CITATIONS
SEARCH DETAIL
...